Aurobindo MD's exit alone may not lift stock, new team must start wellIn six weeks of the cancellation of the Rs 420-crore controversial acquisition of Cronus Pharma, a veterinary products company, the managin...
Analysts welcome Aurobindo calling off stake buy in CronusAurobindo shares have fallen 36% from their 52-week high of Rs 1,063.75 hit on May 11. The company’s lower-than-expected June quarter resul...
Stocks in the news: Nuvoco Vistas, NTPC, Eicher Motors, GAIL and Adani stocksCement maker Nuvoco Vistas will make its Dalal Street debut today. The company may witness a tepid a listing on the bourses.
Aurobindo Pharma says Rs 420 crore deal to acquire 51 per cent in Cronus Pharma cancelledOn August 12, the company had announced that it had entered into definitive agreements to subscribe to fresh equity shares in Hyderabad-bas...
Aurobindo Pharma Q1 net profit declines 2% to Rs 770 crConsolidated total revenue from operations of the company stood at Rs 5,701.98 crore for the quarter under consideration. It was Rs 5,924.7...
Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 crHyderabad-based Cronus is engaged in development, manufacturing and sale of veterinary pharmaceutical products and has a large exposure in ...
US-based Acasti Pharma to buy Indian origin pharma firm GraceAs per the understanding, Acasti will acquire Grace’s entire therapeutic pipeline consisting of three unique clinical stage and multiple pr...
- Sun-like star found eating its own planetary offspring
Washington, Dec 22 (IANS) Researchers have found evidence to show that a Sun-like star 550 light years from Earth is slowly consuming its "...
Wall Street had strong words after the ex-CEO of Lehman gave his first speech in 6 yearsEx-Lehman Brothers CEO Dick Fuld made an impassioned defense of his former company and the decisions made in the 2008 financial crisis.